Evaluation of external validity of the OVHIPEC-1 trial in a real-world population.
Ruby M van SteinKarolina SikorskaMaaike A van der AaGabe S SonkeWillemien J van Drielnull nullPublished in: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2022)
Despite differences in patient characteristics, OS of patients treated in the control arm of OVHIPEC-1 was similar to patients treated outside the trial. The trial population accurately represents real-world patients with stage III EOC undergoing interval CRS in terms of outcome.